Notably, compound 11c significantly reduced tumor growth by induced apoptosis in a mouse subcutaneous tumor implantation model in vivo, suggesting a potential for compound 11c to be further developed as a JAK/STAT3 signaling inhibitor for the treatment of cancer. This evidence concerns the gene STAT3 and neoplasm.